Human T cell Lymphotropic Viral Infection

(HTLV; HTLV-I; HTLV-II)

hu-man tee cel lim-fow-trop-ik v-eye-ral infek-shon

Definition

Human T cell lymphotropic virus (HTLV) infects a type of white blood cell called a T-cell or T-lymphocyte. White blood cells are a type of cell that helps fight infection. HTLV is a type of retrovirus that can cause cancer. It is different than the retrovirus that causes AIDS.

Causes

HTLV infection is caused by a specific virus.

Copyright © Nucleus Medical Media, Inc.

Risk Factors

There are 2 types of HTLV: HTLV-I and HTLV-II.

Factors that may increase the chances of getting HTLV-I:

  • Living in an area where the virus is common such as Southern Japan, Caribbean countries, parts of Africa and South America, the Middle East, and Melanesia
  • Being breastfed by an infected mother
  • Receiving a blood transfusion or transplant in the US before 1988
  • Having unprotected sex with someone who is infected with the virus, who is an injection drug user, or who is from an area where the virus is common
  • Injection drug use

People of American Indian or African Pygmy descent are at greater risk for HTLV-II.

Factors may that increase the chances of getting HTLV-II:

  • Being breastfed by an infected mother
  • Receiving a blood transfusion in the US before 1988
  • Having unprotected sex with someone who is infected with the virus or who is an injection drug user
  • Injection drug use

Symptoms

More than 95% of people with HTLV do not have symptoms. However, having the virus puts you at higher risk of developing certain conditions.

  • If you are infected with the HTLV-I virus, it is possible that you may develop
    • Adult T-cell leukemia (ATL). This disease involves cancer of a specific group of white blood cells.
    • Opportunistic infections, including Strongyloides stercoralis hyperinfection
    • Inflammation of the eyes, joints, muscles, lungs, or skin (rare)

If you are infected with HTLV-I or HTLV-II, you may also develop a disorder of the nervous system known as HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP). It can cause weakness, numbness and stiffness in the legs, and difficulty walking.

Diagnosis

You will be asked about your symptoms and medical history. A physical exam will be done.

HTLV infection can only be diagnosed with a specific blood test. The presence of HTLV antibodies is a sign of infection with the virus.

Treatment

There is no treatment that can remove the virus from the body. Treatment is aimed at managing HTLV-associated diseases and reducing their symptoms.

To prevent spreading HTLV to others:

  • Do not donate plasma, bone marrow, organs, semen, or breast milk.
  • Do not breastfeed your baby.
  • Avoid unprotected sex.
  • Avoid sharing needles or syringes.

Prevention

To help reduce the chances of HTLV infection:

  • Avoid unprotected sex. If your partner has the virus, discuss ways to prevent the spread of the virus with your doctor.
  • Avoid sharing needles or syringes.

RESOURCES:

Centers for Disease Control and Prevention
https://www.cdc.gov
National Institute of Allergy and Infectious Diseases
https://www.niaid.nih.gov

CANADIAN RESOURCES:

The Canadian Hematology Society
http://canadianhematologysociety.org

References:

Human T-cell lymphotropic virus type 1 (HTLV-1). EBSCO DynaMed website. Available at:
...(Click grey area to select URL)
Accessed January 29, 2021.
Human T-lymphotropic virus (HTLV). New York State Office of Alcoholism and Substance Abuse Services website. Available at: https://www.oasas.ny.gov/AdMed/FYI/HTLV-FYI.cfm. Accessed January 29, 2021.
What is HTLV-II? The National Centre for Human Retrovirology website. Available at:
...(Click grey area to select URL)
Accessed January 29, 2021.
Last reviewed March 2020 by EBSCO Medical Review Board David L. Horn, MD, FACP
Last Updated: 1/29/2021

EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.

This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.

To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com. Our Health Library Support team will respond to your email request within 2 business days.

advertisement